trastuzumab
Castle Bio, NantHealth Pace Gainers as 360Dx Index Climbs 4 Percent in December
Of the 32 companies in the index, 21 firms saw their stock prices increase, while 11 firms' share prices decreased.
FDA Approves Roche Breast Cancer Companion Diagnostic for Herceptin
The test detects the HER2 biomarker in breast cancer and can be completed within the same day, allowing for faster results than other HER2 testing methods.
Craig-Hallum Begins Coverage of CDx Firm Celcuity
Celcuity's companion diagnostic platform CELsignia identifies cellular signals corresponding to drug response using a patient's living tumor cells.